{"altmetric_id":2652215,"counts":{"readers":{"mendeley":77,"citeulike":1,"connotea":0},"total":{"posts_count":3},"twitter":{"unique_users_count":3,"unique_users":["OmicsOmicsBlog","matthewherper","hswapnil"],"posts_count":3}},"citation":{"abstract":"To illustrate controversial issues associated with stopping randomized controlled trials (RCTs) early for apparent benefit.","abstract_source":"pubmed","altmetric_jid":"4f6fa4f03cf058f610002cfd","authors":["Bassler D","Montori VM","Briel M","Glasziou P","Guyatt G","Dirk Bassler","Victor M. Montori","Matthias Briel","Paul Glasziou","Gordon Guyatt"],"doi":"10.1016\/j.jclinepi.2007.07.016","endpage":"246","first_seen_on":"2014-09-04T18:30:40+00:00","issns":["08954356"],"issue":"3","journal":"Journal of Clinical Epidemiology","last_mentioned_on":1409796877,"links":["http:\/\/www.ncbi.nlm.nih.gov\/m\/pubmed\/18226746\/"],"pmid":"18226746","pubdate":"2008-01-03T00:00:00+00:00","publisher_subjects":[{"name":"Medical And Health Sciences","scheme":"era"},{"name":"Mathematical Sciences","scheme":"era"}],"scopus_subjects":["Medicine","Health Sciences"],"startpage":"241","subjects":["epidemiology"],"title":"Early stopping of randomized clinical trials for overt efficacy is problematic.","type":"article","uri":"http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0895435607002922","volume":"61","mendeley_url":"http:\/\/www.mendeley.com\/research\/early-stopping-randomized-clinical-trials-overt-efficacy-problematic"},"altmetric_score":{"score":1,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":1},"context_for_score":{"all":{"total_number_of_other_articles":4506051,"mean":5.113311188876,"rank":2327532,"this_scored_higher_than_pct":34,"this_scored_higher_than":1535647,"rank_type":"exact","sample_size":4506051,"percentile":34},"similar_age_3m":{"total_number_of_other_articles":116115,"mean":8.0259787450265,"rank":56177,"this_scored_higher_than_pct":39,"this_scored_higher_than":45598,"rank_type":"exact","sample_size":116115,"percentile":39},"this_journal":{"total_number_of_other_articles":827,"mean":4.7786658595642,"rank":488,"this_scored_higher_than_pct":29,"this_scored_higher_than":247,"rank_type":"exact","sample_size":827,"percentile":29},"similar_age_this_journal_3m":{"total_number_of_other_articles":14,"mean":8.5846153846154,"rank":12,"this_scored_higher_than_pct":14,"this_scored_higher_than":2,"rank_type":"exact","sample_size":14,"percentile":14}}},"demographics":{"poster_types":{"member_of_the_public":1,"researcher":1,"science_communicator":1},"users":{"twitter":{"cohorts":{"Scientists":1,"Science communicators (journalists, bloggers, editors)":1,"Members of the public":1}},"mendeley":{"by_status":{"Professor > Associate Professor":9,"Researcher":13,"Student  > Doctoral Student":3,"Student  > Ph. D. Student":10,"Student  > Postgraduate":9,"Other":6,"Student  > Master":10,"Student  > Bachelor":5,"Lecturer":3,"Professor":8,"Librarian":1},"by_discipline":{"Medicine and Dentistry":51,"Social Sciences":4,"Psychology":1,"Agricultural and Biological Sciences":6,"Nursing and Health Professions":1,"Business, Management and Accounting":2,"Biochemistry, Genetics and Molecular Biology":1,"Mathematics":5,"Unspecified":3,"Pharmacology, Toxicology and Pharmaceutical Science":2,"Philosophy":1}}},"geo":{"twitter":{"US":2,"CA":1},"mendeley":{"NL":1,"US":4,"IT":2,"GB":2,"CH":1,"ES":1}}},"posts":{"twitter":[{"url":"https:\/\/twitter.com\/OmicsOmicsBlog\/status\/507350990853791744","license":"datasift","rt":["hswapnil"],"citation_ids":[2652215],"posted_on":"2014-09-04T02:14:37+00:00","author":{"name":"Keith Robison","url":"http:\/\/omicsomics.blogspot.com","image":"https:\/\/pbs.twimg.com\/profile_images\/859776960058339329\/c0IznW_h_normal.jpg","description":"Computational biologist in drug discovery since '96.","id_on_source":"OmicsOmicsBlog","tweeter_id":"116867280","geo":{"lt":42.3751,"ln":-71.10561,"country":"US"},"followers":4559},"tweet_id":"507350990853791744"},{"url":"https:\/\/twitter.com\/matthewherper\/status\/507282554324803584","license":"datasift","rt":["hswapnil"],"citation_ids":[2652215],"posted_on":"2014-09-03T21:42:40+00:00","author":{"name":"Matthew Herper","url":"http:\/\/blogs.forbes.com\/matthewherper","image":"https:\/\/pbs.twimg.com\/profile_images\/804670477939724288\/qMG4aBwA_normal.jpg","description":"Forbes reporter covering science and medicine","id_on_source":"matthewherper","tweeter_id":"44438256","geo":{"lt":43.00035,"ln":-75.4999,"country":"US"},"followers":76105},"tweet_id":"507282554324803584"},{"url":"https:\/\/twitter.com\/hswapnil\/status\/507280490605596674","license":"datasift","citation_ids":[2652215],"posted_on":"2014-09-03T21:34:28+00:00","author":{"name":"Swapnil Hiremath, MD","url":"http:\/\/about.me\/swapnil.hiremath","image":"https:\/\/pbs.twimg.com\/profile_images\/730502747754139649\/hP6Q9DDQ_normal.jpg","description":"Nephrologist, Mumbai|Boston|Ottawa. #NephJC cofounder. Work at @ottawahospital @uottawamed @ottawarenal Opinions personal etc\/No pharma conflicts","id_on_source":"hswapnil","tweeter_id":"23789628","geo":{"lt":45.41117,"ln":-75.69812,"country":"CA"},"followers":3903},"tweet_id":"507280490605596674"}]}}